PHI Board member Jan Richardsson recently divested 5 328 shares in the company.
“The reason for the sale is that I needed to balance an option loss linked to a previous employment”, comments Richardsson.
After the sale, Richardsson owns 38 634 shares in PHI, privately and via companies.
Despite a summer-sluggish period ending in July, sales were just one unit away from surpassing our best quarter ever; the same period last year.
PHI visits the WFIRM to finalize an agreement concerning the automation of advanced quality control in large-scale biomanufacturing of regenerative therapies.
Sales more than doubled in 2021/22, compared to previous financial year.